202 related articles for article (PubMed ID: 24698158)
21. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
Boivin G; Gaudreau A; Routy JP
AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
[TBL] [Abstract][Full Text] [Related]
22. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.
Siripassorn K; Manosuthi W; Chottanapund S; Pakdee A; Sabaitae S; Prasithsirikul W; Tunthanathip P; Ruxrungtham K;
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):139-48. PubMed ID: 20156097
[TBL] [Abstract][Full Text] [Related]
24. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.
Casper C; Krantz EM; Corey L; Kuntz SR; Wang J; Selke S; Hamilton S; Huang ML; Wald A
J Infect Dis; 2008 Jul; 198(1):23-30. PubMed ID: 18491970
[TBL] [Abstract][Full Text] [Related]
25. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Cannon MJ; Dollard SC; Black JB; Edlin BR; Hannah C; Hogan SE; Patel MM; Jaffe HW; Offermann MK; Spira TJ; Pellett PE; Gunthel CJ
AIDS; 2003 Jan; 17(2):215-22. PubMed ID: 12545082
[TBL] [Abstract][Full Text] [Related]
27. Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma.
Carleo MA; Di Martino F; Del Giudice A; Gargiulo M; Parrella G; Rosario P; Sangiovanni V; Viglietti R; Esposito V; Chirianni A
In Vivo; 2015; 29(1):133-6. PubMed ID: 25600542
[TBL] [Abstract][Full Text] [Related]
28. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men.
Casper C; Redman M; Huang ML; Pauk J; Lampinen TM; Hawes SE; Critchlow CW; Morrow RA; Corey L; Kiviat N; Wald A
J Acquir Immune Defic Syndr; 2004 Mar; 35(3):233-8. PubMed ID: 15076237
[TBL] [Abstract][Full Text] [Related]
29. High Seroprevalence of Human Herpesvirus 8 Infection in HIV-positive Homosexual Men in Jiangsu Province, China.
Li J; Song J; Tan G; Wang J; Zhou Z; Wu X
Curr HIV Res; 2017; 15(4):273-278. PubMed ID: 28606034
[TBL] [Abstract][Full Text] [Related]
30. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763
[TBL] [Abstract][Full Text] [Related]
31. Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
Hammer SM; Vaida F; Bennett KK; Holohan MK; Sheiner L; Eron JJ; Wheat LJ; Mitsuyasu RT; Gulick RM; Valentine FT; Aberg JA; Rogers MD; Karol CN; Saah AJ; Lewis RH; Bessen LJ; Brosgart C; DeGruttola V; Mellors JW;
JAMA; 2002 Jul; 288(2):169-80. PubMed ID: 12095381
[TBL] [Abstract][Full Text] [Related]
32. Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy.
Pasternak AO; Vroom J; Kootstra NA; Wit FW; de Bruin M; De Francesco D; Bakker M; Sabin CA; Winston A; Prins JM; Reiss P; Berkhout B;
Elife; 2021 Aug; 10():. PubMed ID: 34387543
[TBL] [Abstract][Full Text] [Related]
33. Human herpesvirus 8: current issues.
Cannon MJ; Laney AS; Pellett PE
Clin Infect Dis; 2003 Jul; 37(1):82-7. PubMed ID: 12830412
[TBL] [Abstract][Full Text] [Related]
34. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
35. Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
Crane HM; Van Rompaey SE; Kitahata MM
AIDS Patient Care STDS; 2007 Dec; 21(12):920-9. PubMed ID: 18154489
[TBL] [Abstract][Full Text] [Related]
36. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
37. A prospective comparison of the two main indications of efavirenz in 2001 highly active antiretroviral therapy (HAART) regimens: first-line versus salvage use.
Manfredi R; Calza L; Chiodo F
J Antimicrob Chemother; 2002 May; 49(5):723-9. PubMed ID: 12003964
[TBL] [Abstract][Full Text] [Related]
38. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.
Cattani P; Capuano M; Cerimele F; La Parola IL; Santangelo R; Masini C; Cerimele D; Fadda G
J Clin Microbiol; 1999 Apr; 37(4):1150-3. PubMed ID: 10074540
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily.
Viviano E; Vitale F; Ajello F; Perna AM; Villafrate MR; Bonura F; Aricò M; Mazzola G; Romano N
AIDS; 1997 Apr; 11(5):607-12. PubMed ID: 9108942
[TBL] [Abstract][Full Text] [Related]
40. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.
Cattelan AM; Calabro ML; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
Eur J Cancer; 1999 Dec; 35(13):1809-15. PubMed ID: 10673996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
